AVROBIO stockholders approve plan amendment increasing authorized shares to 13,486,099

Tectonic Therapeutic, Inc.

Elected Gail Farfel, Christopher Paige, and Philip Vickers as Class I directors with over 20M votes each.
Ratified Ernst & Young as independent auditor for FY2022 with 33.8M votes for, 57,906 against.
Approved amendment to 2018 Stock Plan adding 13,486,099 shares and imposing 12-month minimum vesting (excluding 5% pool).
Shares forfeited after March 2, 2022 will be added back to the plan reserve under the amended terms.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.